Quantcast

Latest Regulus Therapeutics Stories

2014-10-30 16:29:15

LA JOLLA, Calif., Oct. 30, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.

2014-10-28 20:24:05

LA JOLLA, Calif., Oct.

2014-10-27 16:27:52

LA JOLLA, Calif., Oct.

2014-10-22 08:31:10

- Interim Results from Ongoing Study Demonstrate Human Proof-of-Concept and Underscore the Value of Regulus' microRNA Platform - LA JOLLA, Calif., Oct.

2014-10-14 08:32:24

-New Preclinical Results Increase Mechanistic Understanding of Targeting miR-103/107 for Metabolic Disorders and miR-21 for Renal Dysfunction in Alport Syndrome Patients- LA JOLLA, Calif.,

2014-10-09 08:27:08

CARLSBAD, Calif., Oct. 9, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.

2014-10-01 08:30:41

CARLSBAD, Calif., Oct. 1, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.

2014-09-24 08:27:53

-Newly Allowed Claims Demonstrate Regulus' Leadership in the microRNA Field- LA JOLLA, Calif., Sept.

2014-09-18 08:29:26

-ATHENA to Shed Light on Rare, Life-Threatening Kidney Disease - LA JOLLA, Calif., Sept.

2014-09-09 12:28:35

PORTLAND, Oregon, September 9, 2014 /PRNewswire/ -- A new report by Allied Market Research, titled "RNA Therapeutics Market (technology, applications, end user and geography)


Word of the Day
ultimo
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
The word 'ultimo' comes from the Latin phrase 'ultimo mense', 'in the last month'.
Related